Belgium · Series D startup
Funding summaryUpdated 26 Oct 2026
$77Mraised across 4 rounds since 2015, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Korea Investment Partners
Gates FoundationTakeda Pharmaceutical
The Innovation FundInventures IITheClubDealMissing a round, or an investor who was in one? Tell us.
These 2 firms list Univercells as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Univercells's investors include Korea Investment Partners, Gates Foundation, Takeda Pharmaceutical, The Innovation Fund and Inventures II, and 1 more on record.
Univercells has raised $77M across 4 rounds since 2015.
Univercells's most recent round was a Series D of $43M in Oct 2022.
Its most recent round, $43M in Oct 2022, is also its largest on record.
Univercells's first round on record, in Oct 2015, was backed by Takeda Pharmaceutical.
Univercells's latest named round is a Series D, in Oct 2022.
Univercells is based in Belgium.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Belgium · 
